AstraZeneca Strikes 'Most Favored Nation' Price Deal
By Dan McKay · October 10, 2025, 9:02 PM EDT
Pharmaceutical giant AstraZeneca on Friday cut a deal with the Trump administration to reduce drug prices in the United States, agreeing to provide its medications for Medicaid beneficiaries at discount prices....
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login